CM Life Sciences III Inc.

Status: Deal Closed
U=S+W/5 W=S@11.5
IPO Proceeds, $M $552.00M
IPO Date Apr 7, 2021
CEO Eli D. Casdin
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences

IPO Geography Global
Target Company EQRx
Deal Announced Aug 6, 2021
Deal Size, $M $3,538.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Dec 16, 2021
Amendment Vote TBD
Closing Date Dec 17, 2021
Formerly CMLT EQRX EQRXW

Sign up for Free Trial

No credit card required

Sign in for more on CM Life Sciences III Inc.:

  • Structure and cap table
  • 9 directors & officers
  • 19 filings and events
  • 2 underwriters
  • 8 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Eli D. Casdin 47 Chief Executive Officer and Director
Keith A. Meister 47 Chairman
Brian Emes 38 Chief Financial Officer and Secretary
Shaun Rodriguez 42 Chief Strategy Officer
Christian Henry 53 Director
Kwame Owusu-Kesse 36 Director
Chad Robins 46 Director
Harlan Robins 47 Director
Dr. Amy Abernethy Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Jefferies Joint BR 28,800,000 units
Cowen Joint BR 19,200,000
48,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 19 filings.

Shareholders

Sign in to view shareholders 13F filing data.